Treatments for depression are getting more and more innovative by the day. The Food and Drug Administration has just added another unusual treatment option to the list: A ketamine-like nasal spray that will help to treat drug-resistant depression.
According to CNN,the drug is actually esketamine, which is “the chemical cousin of ketamine.”The drug was assign forward by Janssen Pharmaceuticals Inc., or under the Johnson & Johnson brand,after extensive research last year showed promising results with regards to treating the condition, per a previous report by The Inquisitr.
Although it has been approved, and there are still restrictions on the exercise of the drug,with patients having to show that they believe tried other methods to treat their depression and that they are failing to do so with other medications. whether approved for the exercise of the drug, an verbal anti-depressant must still be taken in conjunction with the esketamine, and which is being marketed as Spravato.
Click here to continue and read more...
Source: inquisitr.com